Ferring Fights To Revive Drug IP Inventorship Dispute

By Britain Eakin · September 4, 2020, 6:01 PM EDT

A Federal Circuit panel on Thursday questioned why Ferring Pharmaceuticals waited seven years to challenge the inventorship of three patents that an ex-employee sold to Allergan in a $43 million deal...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Ferring B.V. v. Allergan, Inc.

Case Number

20-1098

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

October 30, 2019